Astec LifesciencesNSE:ASTEC -1.76%74 Days Payable is 72.50 as of Mar. 2026, which is 46% below its 10-year median of 134.29. GuruFocus rates NSE:ASTEC with a GF Score™ of 74/100 and a GF Value™ of ₹976.99 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 246 Agriculture companies, Astec Lifesciences ranks better than 67.48% on this metric.
The historical rank and industry rank for Astec Lifesciences's Days Payable or its related term are showing as below:
NSE:ASTEC'
s Days Payable Range Over the Past 10 Years
Min: 103.52 Med: 134.29 Max: 174.76
Current: 107.69
During the past 13 years, Astec Lifesciences's highest Days Payable was 174.76. The lowest was 103.52. And the median was 134.29.
NSE:ASTEC's Days Payable is ranked better than 67.48% of 246
companies
in the Agriculture industry
Industry Median: 72.7
vs NSE:ASTEC: 107.69
Astec Lifesciences's Days Payable
declined
from Mar. 2025 (101.27) to Mar. 2026 (72.50).
It may suggest that Astec Lifesciencesaccelerated paying its suppliers.
Astec Lifesciences Days Payable Related Terms
Astec Lifesciences Days Payable Historical Data
* Premium members only.
The historical data trend for Astec Lifesciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTEC vs CTVA, CF, MOS: Days Payable Comparison
For the Agricultural Inputs subindustry, Astec Lifesciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences Days Payable vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Astec Lifesciences's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astec Lifesciences (NSE:ASTEC) has a Days Payable of 72.50 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Astec Lifesciences and its competitors. This is 46% below median its historical median of 134.29. Over the past decade, Astec Lifesciences' Days Payable has ranged from 103.52 to 174.76. According to the industry distribution chart, Astec Lifesciences ranks #80 out of 246 companies in the Agriculture industry, placing it in the top 32.5%.
Is Astec Lifesciences' Days Payable too high?
Astec Lifesciences' current Days Payable of 72.50 is 46% below median its 10-year median of 134.29. Over the past 10 years, this metric has ranged from a low of 103.52 to a high of 174.76. The Agriculture industry median Days Payable is 72.70. Astec Lifesciences' value of 72.50 is 0.3% below this industry median. Based on the distribution chart, Astec Lifesciences ranks #80 out of 246 companies in the Agriculture industry, which is above the industry midpoint. Overall, Astec Lifesciences has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Days Payable compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #80 out of 246 companies for Days Payable. This puts Astec Lifesciences in the upper half of its industry. The industry median Days Payable is 72.70. Astec Lifesciences' value of 72.50 is 0.3% below this benchmark. Historically, Astec Lifesciences' own Days Payable has ranged from 103.52 to 174.76 over the past decade. While the company's 10-year median is 134.29 vs. the industry median of 72.70, Astec Lifesciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Agriculture company?
The median Days Payable among Agriculture companies is 72.70, based on 246 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astec Lifesciences's current Days Payable of 72.50 is 0.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Astec Lifesciences and its competitors. For the Agriculture industry, the median Days Payable is 72.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astec Lifesciences's current Days Payable is 72.50, which is 46% below median its own 10-year median of 134.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹976.99, compared to a current price of ₹712.70 — trading 27.1% below its estimated fair value. The current Days Payable is 72.50, which is 46% below median its 10-year median of 134.29 and 0.3% below the Agriculture industry median of 72.70. Astec Lifesciences' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Days Payable is 72.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued.
The current stock price of ₹712.70 is trading 27.1% below its estimated GF Value™ of ₹976.99.
GuruFocus considers Astec Lifesciences to be Modestly Undervalued.
Key valuation signals for NSE:ASTEC:
Days Payable: 72.50 (46% below median its 10-year median of 134.29)
GF Value™: ₹976.99 vs. price of ₹712.70 (27.1% below fair value)
Industry Position: 0.3% below the Agriculture median (#80 of 246)
No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
74GF Score
Get the complete analysis for NSE:ASTEC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTEC has been successfully added to your 
